載入...
Non-vitamin K antagonist oral anticoagulants in cancer patients with atrial fibrillation
To the best of our knowledge, non-vitamin K antagonist oral anticoagulants (NOACs), or direct oral anticoagulants, have not been tested in randomized trials conducted in patients with atrial fibrillation (AF), affected by malignant disease. However, their use in patients with cancer is increasing, w...
Na minha lista:
| 發表在: | Anatol J Cardiol |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Kare Publishing
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7141434/ https://ncbi.nlm.nih.gov/pubmed/31911561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14744/AnatolJCardiol.2019.30766 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|